• Klinische Versorgungsforschung
• Epidemiologie
• Public Health

• Wiessing L, Banka-Cullen P, Barbaglia MG, Belackova V, Belbaisi SA, Blanken P, Carrieri P, Comiskey C, Dacosta-Sánchez D, Dom G, Fabricius V, Faria H, Ignjatova L, Inić N, Jacobsen B, Javakhishvili D, Kamendy Z, Kapitány-Fövény Kiss A, Kyprianou E, Marchand K, Millar T, Mravcik V, Naser JYM, Nordt C, Partanen M, Pedersen M, Putkonen H, Razmadze M, Roux P, Schulte B, Seabra P, Sordo L, Strada L, Subata E, Thoma E, Torrens M, Walley A, Yiasemi I for the OPTIMUS study group (2024). Opioid Agonist Maintenance Treatment Outcomes-The OPTIMUS International Consensus Towards Evidence-Based and Patient-Centred Care, an Interim Report. International Journal of Mental Health and Addiction. 10.1007/s11469-023-01213-9.
• Manthey J, Jacobsen B, Klinger S, Schulte B, Rehm J (2023) Restricting alcohol marketing to reduce alcohol consumption: A systematic review of the empirical evidence for one of the ‘best buys’. Addiction. https://doi.org/10.1111/add.16411
• Kilian C, Carr S, Schulte B, Manthey J (2023) Increased alcohol-specific mortality in Germany during COVID-19: State-level trends from 2010 to 2020. Drug Alcohol Rev;42(3):633-640. doi: 10.1111/dar.13573.
• Lehmann K, Kuhn S, Schulte B, Verthein U (2023) Changes in Opioid Agonist Treatment Practice in Germany during the COVID-19 Pandemic: What Have Physicians Done, and What Would They Like to Keep Doing? Eur Addict Res. 9:1-10. doi: 10.1159/000531593
• Manthey J, Kilian C, Schäfer I, Wirth M, Schulte B (2023) Changes in the alcohol-specific disease burden during the COVID-19 pandemic in Germany: interrupted time series analyses. European journal of public health. doi:10.1093/eurpub/ckad103
• Möckl J, Lindemann C, Manthey J, Schulte B, Reimer J, Pogarell O, Kraus, L (2023) Estimating the prevalence of alcohol-related disorders and treatment utilization in Bremen 2016/2017 through routine data linkage. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1002526
• Kilian C, Carr S, Schulte B, Manthey J (2022) Increased alcohol-specific mortality in Germany during COVID-19: State-level trends from 2010 to 2020. Drug and Alcohol Review, 42(3), 633-640. https://doi.org/10.1111/dar.13573
• Kokole D, Jané-Llopis E, Mercken L, Natera Rey G, Arroyo M, Pérez Gómez A, Mejía-Trujillo J, Piazza M, Bustamante I, O'Donnell A, Kaner E, Schulte B, de Vries H, Anderson P (2022) Protocol for a process evaluation of SCALA study - Intervention targeting scaling up of primary health care-based prevention and management of heavy drinking and comorbid depression in Latin America. Eval Program Planning 97:102217. doi: 10.1016/j.evalprogplan.2022.102217
• Verthein U, Lahusen H, Martens MS, Prilutskaya M, Yussopov O, Kaliyeva Z, Schulte B (2022) Alcohol Screening and Brief Intervention in Primary Health Care in Kazakhstan—Results of a Cluster Randomised Pilot Study. International Journal of Public Health; 67. DOI: 10.3389/ijph.2022.1604803
• O'Donnell A, Anderson P, Schmidt C, Braddick F, Lopez-Pelayo H, Mejía-Trujillo J, Natera G, Arroyo M, Bautista N, Piazza M, Bustamante IV, Kokole D, Jackson K, Jane-Llopis E, Gual A, Schulte B. (2022) Tailoring an evidence-based clinical intervention and training package for the treatment and prevention of comorbid heavy drinking and depression in middle-income country settings: the development of the SCALA toolkit in Latin America. Glob Health Action. 2022 Dec 31;15(1):2080344. doi: 10.1080/16549716.2022.2080344
• Carr S, Lindemann C, Kraus L, Rehm J, Schulte B, Manthey J (2022) Alcohol Consumption Levels and Health Care Utilization in Germany. SUCHT;68:151-60
• Schulte B, Jacobsen B, Kuban M, Kraus L, Reimer J, Schmidt CS, Schäffer D (2022) Umsetzung von Testung, Diagnostik und Behandlung der Hepatitis C in Einrichtungen der niedrigschwelligen Drogenhilfe in Deutschland – eine Querschnittsbefragung. Suchttherapie, eFirst; DOI: 10.1055/a-1824-7646
• Frischknecht U, Hoffmann S, Steinhauser A, Lindemann C, Buchholz A, Manthey J, Schulte B, Rehm J, Kraus L, Verthein U, Reimer J, Kiefer F (2022) Screening auf problematischen Alkoholkonsum – Erhebung zur Umsetzung der S3-Leitlinienempfehlungen in der transdisziplinären Versorgung einer Modellregion. Gesundheitswesen; 84(1):43-51. doi: 10.1055/a-1276-0475
• O'Donnell A, Schmidt CS, Beyer F, Schrietter M, Anderson P, Jane-Llopis E, Kaner E, Schulte B (2022) Effectiveness of digital interventions for people with comorbid heavy drinking and depression: A systematic review and narrative synthesis. J Affect Disord; 298:10-23. doi: 10.1016/j.jad.2021.11.039
• Kuhn S, Lehmann K, Schulte B, Verthein U (2022) Opioidsubstitutionstherapie im Rahmen der neuen Betäubungsmittel-Verschreibungsverordnung aus Sicht von Apothekerinnen und Apothekern. Z Evid Fortbild Qual Gesundhwes;168:57-64. doi: 10.1016/j.zefq.2021.10.003
• Manthey J, Carr S, Anderson P, Bautista N, Braddick F, O'Donnell A, Jané-Llopis E, López-Pelayo H, Medina P, Mejía-Trujillo J, Pérez-Gómez A, Piazza M, Rehm J, Solovei A, Rey GN, de Vries H, Schulte B (2022) Reduced alcohol consumption during the COVID-19 pandemic: Analyses of 17 000 patients seeking primary health care in Colombia and Mexico. J Glob Health; 12:05002. doi: 10.7189/jogh.12.05002
• Kilian C, O'Donnell A, Potapova N, López-Pelayo H, Schulte B, Miquel L, Paniello Castillo B, Schmidt CS, Gual A, Rehm J, Manthey J (2022) Changes in alcohol use during the COVID-19 pandemic in Europe: A meta-analysis of observational studies. Drug Alcohol Rev; 41:918-931. doi: 10.1111/dar.13446
• Buchholz A, Spies M, Härter M, Lindemann C, Schulte B, Kiefer F, Frischknecht U, Reimer J, Verthein U (2022) Barrieren und Umsetzungsstrategien für die Implementierung der S3-Leitlinie Screening, Diagnose und Behandlung alkoholbezogener Störungen aus Sicht von Behandlern und Betroffenen. Suchttherapie; 23(02): 66-76. DOI: 10.1055/a-1324-5217
• Lehmann K, Kuhn S, Schulte B, Verthein U (2022) Relevanz und Auswirkungen der 3. BtMVVÄndV für die Opioidsubstitutionstherapie. Suchttherapie; 23: 33–43. DOI: 10.1055/a-1330-6349
• Scholz-Hehn AD, Milin S, Schulte B, Reimer J, Buth S, Schäfer I (2022) Substance Use and Chemsex in MSM – A Latent Class Analysis. Journal of Drug Issues; 52: 83–96
• Frischknecht U, Hoffmann S, Steinhauser A, Lindemann L, Buchholz A, Manthey J, Schulte B, Rehm J, Kraus L, Verthein U, Reimer J, Kiefer F (2021) Diagnostik und Behandlung alkoholbezogener Störungen – Versorgerbefragung zur Erarbeitung von Strategien der Leitlinienimplementierung. Suchttherapie; 22: 141 - 151. DOI 10.1055/a-1265-4687
• O'Donnell A, Schulte B, Manthey J, Schmidt CS, Piazza M, Chavez IB, Natera G, Aguilar NB, Hernández GYS, Mejía-Trujillo J, Pérez-Gómez A, Gual A, de Vries H, Solovei A, Kokole D, Kaner E, Kilian C, Rehm J, Anderson P, Jané-Llopis E (2021) Primary care-based screening and management of depression amongst heavy drinking patients: Interim secondary outcomes of a three-country quasi-experimental study in Latin America. PLoS One, 5;16. doi: 10.1371/journal.pone.0255594
• Kilian C, Rehm J, Allebeck P, Braddick F, Gual A, Barták M, Bloomfield K, Gil A, Neufeld M, O'Donnell A, Petruželka B, Rogalewicz V, Schulte B, Manthey J, the European Study Group on Alcohol Use and COVID-19 (2021) Alcohol consumption during the COVID-19 pandemic in Europe: a large-scale cross-sectional study in 21 countries. Addiction, https://doi.org/10.1111/add.15530
• Kilian C, Rehm J, Allebeck P, Barták M, Braddick F, Gual A, Matrai S, Petruželka B, Rogalewicz V, Rossow I, Schulte B, Štelemekas M, Manthey J (2021) Conducting a multi-country online alcohol survey in the time of the COVID-19 pandemic: Opportunities and challenges. Int J Methods Psychiatr Res. doi: 10.1002/mpr.1875
• Manthey J, Kilian C, Carr S, Allebeck P, Braddick F, Gual A, Barták M, Bloomfield K, Gil A, Neufeld M, O’Donnell A, Petruželka B, Rogalewicz V, Schulte B, Rehm J (2021) Use of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance users. Subst Abuse Treat Prev Policy 16, 36. https://doi.org/10.1186/s13011-021-00373-y
• Kokole D, Jané-Llopis E, Mercken L, Piazza M, Bustamante I, Natera Rey G, Medina P, Pérez-Gómez A, Mejía-Trujillo J, O'Donnell A, Kaner E, Gual A, Schmidt CS, Schulte B, Candel MJJM, de Vries H, Anderson P (2021) Factors associated with primary health care providers' alcohol screening behavior in Colombia, Mexico and Peru. Subst Abus; 13:1-9. doi: 10.1080/08897077.2021.1903658
• Lehmann K, Kuhn S, Schulte B, Meyer-Thompson HG, Verthein U (2021) Die Substitutionstherapie Opioidabhängiger in Deutschland: Auswirkungen der 3. BtMVVÄndV aus der Sicht substituierender Ärztinnen und Ärzte. Gesundheitswesen, eFirst, DOI: 10.1055/a-1378-9249
• Kokole D, Mercken L, Jané-Llopis E, Natera Rey G, Arroyo M, Medina P, Pérez-Gómez A, Mejía-Trujillo J, Piazza M, Bustamante IV, O'Donnell A, Kaner E, Gual A, Lopez-Pelayo H, Schulte B, Manthey J, Rehm J, Anderson P, de Vries H (2021) Perceived appropriateness of alcohol screening and brief advice programmes in Colombia, Mexico and Peru and barriers to their implementation in primary health care - a cross-sectional survey. Prim Health Care Res Dev, 28;22:e4. doi: 10.1017/S1463423620000675
• Anderson P, Manthey J, Llopis EJ, Rey GN, Bustamante IV, Piazza M, Aguilar PSM, Mejía-Trujillo J, Pérez-Gómez A, Rowlands G, Lopez-Pelayo H, Mercken L, Kokole D, O'Donnell A, Solovei A, Kaner E, Schulte B, de Vries H, Schmidt C, Gual A, Rehm J. (2021) Impact of Training and Municipal Support on Primary Health Care-Based Measurement of Alcohol Consumption in Three Latin American Countries: 5-Month Outcome Results of the Quasi-experimental Randomized SCALA Trial. J Gen Intern. doi: 10.1007/s11606-020-06503-9
• Raj N, Verthein U, Grundmann J, Lotzin A, Hiller P, Schulte B, Driessen M, Hillemacher T, Scherbaum N, Schäfer M, Schneider B, Schäfer I (2021) Internalizing and externalizing subtypes in female patients with co-occurring post-traumatic stress disorder and substance use disorders. J Subst Abuse Treat;121:108198. doi: 10.1016/j.jsat.2020.108198. 
• Manthey J, Lindemann C, Kraus L, Reimer J, Verthein U, Schulte B, Rehm J (2020) The potential effects of an extended alcohol withdrawal treatment programme on morbidity and mortality among inpatients in the German city of Bremen: a simulation study. Subst Abuse Treat Prev Policy; 2:15. doi: 10.1186/s13011-019-0249-7
• Manthey J, Lindemann C, Verthein U, Frischknecht U, Kraus L, Reimer J, Grün A, Kiefer F, Schulte B, Rehm J (2020) Versorgung von Personen mit riskantem Alkoholkonsum und schwerer Alkoholkonsumstörung in Bremen: bedarfsgerecht und leitlinienkonform? Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz; 63:122-130. doi: 10.1007/s00103-019-03072-z
• Kahl J, Holl J, Grundmann J, Lotzin A, Hiller P, Schroeder K, Schulte B, Barnow S, Schäfer I (2020)  Difficulties in emotion regulation as an underlying mechanism for the development and maintenance of PTSD in female patients with substance use disorders. Substance Use & Misuse, 55:13, 2184-2193, DOI: 10.1080/10826084.2020.1797805
• Schulte B, Lehmann K, Schmidt CS, Rühling E, Weber B, Schäfer I, Reimer J, Verthein U (2020) Addiction recovery among opioid-dependent patients treated with injectable subcutaneous depot buprenorphine: Study protocol of a non-randomized prospective observational study (ARIDE). Frontiers in Psychiatry. doi.org/10.3389/fpsyt.2020.580863
• Manthey J, Kilian C, Schomerus G, Kraus L, Rehm J, Schulte B (2020) Veränderungen im Alkoholkonsum in Deutschland und Europa während des (bisherigen) Höhepunkts der SARS-CoV-2 Pandemie. SUCHT, 66, 1–12
• Schulte B, Schmidt CS, Manthey J, Strada L, Christensen S, Cimander K, Görne H, Khaykin P, Scherbaum N, Walcher S, Mauss S, Schäfer I, Verthein U, Rehm J,  Reimer J (2020) Clinical and Patient-Reported Outcomes of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Among Patients on Opioid Agonist Treatment: A Real-world Prospective Cohort Study. Open Forum Infectious Diseases, https://doi.org/10.1093/ofid/ofaa317
• Jané-Llopis E, Anderson P, Piazza M, O'Donnell A, Gual A, Schulte B, Pérez Gómez A, de Vries H,  Natera Rey G, Kokole D, Bustamante I, Braddick F, Mejía Trujillo J, Solovei A, Pérez De León A, Kaner E, Matrai S, Manthey J, Mercken L, López-Pelayo H, Rowlands G, Schmidt C, Rehm J (2020) Implementing primary healthcare-based measurement, advice and treatment for heavy drinking and comorbid depression at the municipal level in three Latin American countries: final protocol for a quasiexperimental study (SCALA study). BMJ Open, http://dx.doi.org/10.1136/bmjopen-2020-038226
• Verthein U, Buth S, Daubmann A, Martens MS, Schulte B (2020) Trends in risky prescriptions of opioid analgesics from 2011 to 2015 in Northern Germany. Journal of Psychopharmacology; 34(11) 1210–17. doi: 10.1177/0269881120936544
• Schulte B, Schmidt CS, Strada L, Rosenkranz M, Schäfer I, Verthein U, ReimerJ (2020) Hepatitis C Virus Prevalence and Incidence in a Large Nationwide Sample of Patients in Opioid Substitution Treatment in Germany: A Prospective Cohort Study. Clin Infect Dis 6;70:2199-2205. doi: 10.1093/cid/ciz661
• O’Donnell A, Hanratty B, Schulte B, Kaner E (2020) Patients’ experiences of alcohol screening and advice in primary care: a qualitative study. BMC Fam Pract 21, 68. https://doi.org/10.1186/s12875-020-01142-9
• Reiß M, Schulte B, Schmidt CS, Carstens A, Görne H, Kreibich R, Tietje W, Weber B, Schnell T, Verthein U (2020) Selbst- und Fremdbeurteilung von Depressivität bei opioidabhängigen Patienten in Substitutionsbehandlung. Suchttherapie, 21: 25-31. DOI: 10.1055/a-1032-6735
• Schulte B, O’Donnell A, Lahusen H, Lindemann C, Prilutskaya M, Yussopov O, Kaliyeva Z, Martens MS, Verthein U (2020) Feasibility of alcohol screening and brief intervention in primary health care in Kazakhstan: study protocol of a pilot cluster randomised trial. Pilot Feasibility Stud; 6:3 doi:10.1186/s40814-019-0547-x
• Kraus L, Seitz NN, Schulte B, Cremer-Schaeffer P, Braun B, Verthein U, Pfeiffer-Gerschel T (2019) Schätzung der Anzahl von Personen mit einer Opioidabhängigkeit. Dtsch Arztebl Int 2019; 116: 137–43
• Strada L, Schmidt CS, Rosenkranz M, Verthein U, Scherbaum N, Reimer J, Schulte B (2019) Factors associated with health-related quality of life in a large national sample of patients receiving opioid substitution treatment in Germany: A cross-sectional study. Substance Abuse Treatment, Prevention, and Policy; 14:2
• Heddaeus D, Dirmaier J, Daubmann A, Grochtdreis T, König HH, Löwe B, Maehder K, Porzelt S, Rosenkranz M, Schäfer I, Scherer M, Schulte B, von dem Knesebeck O, Wegscheider K, Weigel A, Werner S, Zimmermann T und Härter M (2019) Erprobung eines integrierten und gestuften Behandlungsmodells für psychische Störungen und Komorbiditäten im Hamburger Netzwerk für Versorgungsforschung. Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz. doi:10.1007/s00103-018-2865-1       
• Schulte B, Lindemann C, Buchholz A, Rosahl A, Härter M, Kraus L, Kiefer F, Frischknecht U, Hoffmann S, Wensing M, O'Donnell A, Manthey J, Rehm J, Schäfer I, Verthein U, Reimer J (2019) Tailored interventions to support the implementation of the German national guideline on screening, diagnosis and treatment of alcohol-related disorders: a project protocol. SUCHT; 65: 373-381
• Heddaeus D, Dirmaier J, Brettschneider C, Daubmann A, Grochtdreis T, von dem Knesebeck O, König HH, Löwe B, Maehder K, Porzelt S, Rosenkranz M, Schäfer I, Scherer M, Schulte B, Wegscheider K, Weigel A, Werner S, Zimmermann T, Härter M (2019) Study protocol for the COMET study: a cluster-randomised, prospective, parallel-group, superiority trial to compare the effectiveness of a collaborative and stepped care model versus treatment as usual in patients with mental disorders in primary care. BMJ Open;9:e032408. doi: 10.1136/bmjopen-2019-032408
• Schulte B, Kaner EFS, Beyer F, Schmidt CS, O'Donnell A (2019) Study protocol for asystematic review of evidence for digital interventions for comorbid excessivedrinking and depression in community-dwelling populations. BMJ Open; 17;9:e031503. doi: 10.1136/bmjopen-2019-031503
• Fraser H, Martin NK, Brummer-Korvenkontio H, Carrieri P, Dalgard O, Dillon J, Goldberg D, Hutchinson S, Jauffret-Roustide M, Kåberg M, Matser AA, Midgard H, Mravcik V, Øvrehus A, Prins M, Reimer J, Robaeys R, Schulte B, van Santen DK, Zimmermann R, Vickerman P, Hickman M (2018) Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe. Journal of hepatology, 68: 402-411
• Grundmann J, Lincoln T, Lüdecke D, Bong S, Schulte B, Verthein U & Schäfer I (2018) Traumatic Experiences, Revictimization and Posttraumatic Stress Disorder in German Inpatients Treated for Alcohol Dependence. Substance Use & Misuse, 53: 677-685
• Strada L, Vanderplasschen W, Buchholz A,  Schulte B, Muller AE, Verthein U, Reimer J. (2017) Measuring quality of life in opioid-dependent people: a systematic review of assessment instruments. Qual Life Res. https://doi.org/10.1007/s11136-017-1674-6
• Anderson P, O'Donnell A, Kaner E, Gual A, Schulte B, Perez-Gomez A, deVries H, Natera G, Rehm J (2017) Scaling-up primary health care-based prevention and management of alcohol use disorder at the municipal level in middle-income countries in Latin America: Background and pre-protocol for a three-country quasi-experimental study. F1000Research 2017, 6:311 doi: 10.12688/f1000research.11173.1
• Strada L, Franke GH, Schulte B, Reimer J, Verthein U. (2017) Development of OSTQOL: A Measure of Quality of Life for Patients in Opioid Substitution Treatment. Eur Addict Res; 23(5):238-248.
• Rehm J, Anderson P, Prieto JAA, Armstrong I, Aubin HJ, Bachmann M, Bastus NB, Brotons C, Burton R, Cardoso M, Colom J, Duprez D, Gmel G, Gual A, Kraus L, Kreutz R, Liira H, Manthey J, Møller L, Okruhlica L, Roerecke M, Scafato E, Schulte B, Segura-Garcia L, Shield KD, Sierra C, Vyshinskiy K, Wojnar M, Zarco J (2017) Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union. BMC Med 28:173. doi: 10.1186/s12916-017-0934-1
• Rehm J, Prieto J, Beier M, Duhot D, Rossi A, Schulte B, Zarco J, Aubin HJ, Bachmann M, Grimm C, Kraus L, Manthey J, Scafato E, Gual A (2016) The role of alcohol in the management of hypertension in patients in European primary health care practices - A survey in the largest European Union countries. BMC Family Practice 17(1); doi: 10.1186/s12875-016-0529-5
• Kraus L, Hay G, Richardson C, Yargic I, Ilhan M, Ay P, Karasahin F, Pinarci M, Tuncoglu T, Piontek D and Schulte B (2016) Estimating high-risk cannabis and opiate use in Ankara, Istanbul and Izmir. Drug and Alcohol Review, doi: 10.1111/dar.12447
• Schmidt CS, Schulte B, Seo HN, Kuhn S, O Donnell A, Kriston L, Verthein U, Reimer J. (2016) Meta-analysis on the effectiveness of alcohol screening with brief interventions for patients in emergency care settings. Addiction. 2015 Dec 5. doi: 10.1111/add.13263
• Schulte B, Schmidt CS, Strada L, Götzke C, Hiller P, Fischer B, Reimer J (2016) Non-prescribed use of opioid substitution medication: Patterns and trends in sub-populations of opioid users. Int J Drug Pol doi:10.1016/j.drugpo.2015.12.024
• Kraus L, Schulte B, Manthey J, Rehm J (2016) Alcohol screening and alcohol interventions among patients with hypertension in primary health care: an empirical survey of German general practitioners. Addiction Research & Theory: 25:4, 285-92
• Strada L, Schulte B, Schmidt CS, Verthein U, Cremer-Schaeffer P, Kru?ckeberg S, Reimer J (2015) Epidemiology of hepatitis C virus infection among people receiving opioid substitution therapy (ECHO): Study protocol. BMC Infectious Diseases (2015) 15:563 DOI 10.1186/s12879-015-1307-z
• O’Donnell A, Anderson P, Newbury-Birch D, Schulte B, Schmidt C, Reimer J, Kaner E. The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews. Alcohol Alcoholism 2014; 49: 66-78.
• Schmidt CS, McGovern R, Schulte B, O'Donnell A, Lehmann K, Kuhn S, Schäfer I, Newbury-Birch D, Anderson P, Kaner E, Reimer J. Brief Alcohol Interventions in Social Service and Criminal Justice Settings: A Critical Commentary. Br J Soc Work 2014 doi: 10.1093/bjsw/bcu100
• Schulte B, O`Donnell A, Kastner S, Schmidt CS, Schäfer I, Reimer J. Alcohol screening and brief intervention in workplace settings and social services: A comparison of literature. Front. Psychiatry 2014 doi: 10.3389/fpsyt.2014.00131
• Schäfer I, Gromus L, Atabaki A, Pawlis S, Verthein U, Reimer J, Schulte B, Martens M. Are experiences of sexual violence related to special needs in patients with substance use disorders? A study in opioid-dependent patients. Addictive Behaviors 2014: 39; 1691–94
• Mravcik V, Strada L, Reimer J, Schulte B. Hepatitis C treatment uptake and adherence among injecting drug users in the Czech Republic. Epidemiologie, mikrobiologie, imunologie. 2014 Fall;63(4):265-269
• Schulte B, Gonzales-Saiz F, Jeschke P, Reimer J, Schäfer I, Walcher S, Weber B, Verthein U. Die Opiate-Dosage-Adequacy-Scale (ODAS) für die Beurteilung der Angemessenheit der Buprenorphindosierung während der Opiatsubstitution. Suchttherapie 2014; 15: 35-42.
• Schmidt CS, Schön D, Schulte B, Lüth S, Polywka S, Reimer J. Viral hepatitis in alcohol-dependent inpatients – Prevalence, risk factors and treatment uptake. Journal of Addiction Medicine 2013; 7:417-21. doi: 10.1097/ADM.0b013e3182a50817
• Mravcík V, Strada L, Stolfa J, Bencko V, Groshkova T, Reimer J, Schulte B. Factors associated with the uptake, adherence and efficacy of hepatitis C treatment among people who inject drugs: a literature review. Patient Preference and Adherence 2013; 7:1067-1075
• Reimer J, Schmidt CS, Schulte B, Gansefort D, Gölz J, Gerken G, Scherbaum N, Verthein U, Backmund M. Psychoeducation improves hepatitis C virus treatment during opioid substitution therapy: a controlled, prospective multicenter trial. Clin Infect Dis. 2013 Aug;57 Suppl 2:S97-104. doi: 10.1093/cid/cit307.
• Schulte B, Schmidt CS, Schäfer I, Fischer B, Wedemeyer H, ReimerJ. Structural barriers in the context of opiate substitution treatment in Germany. Substance Abuse, Treatment, Prevention & Policy 2013; 8:26
• Reimer J, Schmidt CS, Schulte B, Gansefort D, Gölz J, Gerken G, Scherbaum N, Verthein U, Backmund M.  Psychoeducation improves hepatitis C virus therapy outcomes in opioid-substituted patients: A controlled, prospective multicentre trial. Clinical infectious diseases 2013; 57 Suppl 2: 97-S104.
• O’Donnell A, Kaner E, Newbury-Birch D, Schulte B, Schmidt C, Reimer J, Anderson P. Efficacious, effective but still erratic: what will it take to get routine delivery of brief interventions for alcohol in primary healthcare settings? Alcohol & Alcoholism 2013; 49 doi:10.1093/alcalc/agt170
• Schmidt CS, Schulte B, Wickert C, Thane K, Kuhn S, Verthein U, Reimer J. Non-prescribed use of substitution medication among German drug users – Prevalence, motives and availability. International Journal of Drug Policy, 2013;24:e111-4. doi:10.1016/j.drugpo.2013.04.006
• Mravcík V, Škarupová K, Orlíková B, Zábranský T, Karachaliou K, Schulte B (2011) Use of gelatine capsules for application of methamphetamine: A new harm reduction approach. Int J Drug Policy 22, 172-173
• Mravcík V, Škacupová K, Orlíková B, Zábranský T, Karachaliou K, Schulte B (2011) Use of gelatine capsules for application of methamphetamine: A new harm reduction approach. Int J Drug Policy 22, 172-173 Abstract
• Schulte B, Schütt S, Brack J, Isernhagen K, Deibler P, Dilg C, Verthein U, Haasen C. Reimer J (2010) Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance. Drug and Alcohol Dependence 109: 248-251
• Keppler K, Stöver H, Schulte B, Reimer J (2010) Prison health is public health! Problems in adapting and implementing health services for prisoners in Germany. Bundesgesundheitsblatt 53, 233–244
• Haasen C, Schulte B, Vanderplasschen W, Verthein U, Schäfer I, Reimer J: Predictive value of regular cocaine use among opioid-dependent patients for long-term outcome. Addictive Disorders & Their Treatment, 2009; 8:74-79
• Schulte B, Stöver H, Thane K, Schreiter C, Gansefort D, Reimer J. Substitution treatment and HCV- / HIV-infection in a sample of 31 German prisons for sentenced inmates. International Journal of Prisoner Health 2009; 5: 38-44.
• Reimer J, Schulte B, Thane K: Hepatitis and HIV care in prisons, an overview. Suchtmedizin in Forschung und Praxis, 2009. 11(5): S. 223-226
• Schulte B, Gansefort D, Stöver H, Reimer J. Strukturelle Hemmnisse in der Substitution und infektiologischen Versorgung Opiatabhängiger. Suchttherapie 2009; 10; 125-130.
• Reimer J, Schulte B, Schreiter C, Haasen C: Suchtmedizinische Versorgung in deutschen Justizvollzugsanstalten. Nervenarzt, 2007; 78(Suppl.2):381
• Reimer J, Schulte B, Gölz J, Haasen C, Backmund M: PERMIT-Studie: Psychoeducation reaches HCV-infected Methadone/Buprenorphine substituted patients in standard antiviral treatment. Suchtmedizin, 2007; 9:101
• Reimer J, Schulte B, Schaefer I, Backmund M, Haasen C (2005). Hepatitis C bei Drogengebrauchern. Suchttherapie; 6: 28-30.
• Reimer J, Schulte B, Castells X, Schaefer I, Polywka S, Hedrich D, Wiessing L Haasen C, Backmund M, Krausz M (2005). Guidelines for treatment of hepatitis C virus infection in injecting drug users: status quo in the European Union countries. Clinical Infectious Diseases; 40 Suppl5: S373-S378.
• Hedrich D, Schulte B, Reimer J (2004) Analyse der Leitlinien zur Hepatitis-C-Behandlung in den Ländern der Europäischen Union und Norwegen in Bezug auf den Behandlungszugang von DrogenkonsumentInnen. In: akzept, Deutsche Aidshilfe, LaBAS (Hrsg.): 1. Internationaler Fachtag Hepatitis C Berlin 2004. Innovative Konzepte und Praxis von Prävention und Psychosozialer Betreuung nach Drogengebrauch. Seiten 36-41. Berlin, akzept.
• Reimer J, Schulte B, Haasen C, Krausz M (2004). Epidemiologie der Sucht. In: Backmund M (Hrsg.). Suchttherapie – Grundlagen, Klinik, Standards: Leitfaden für Praxis und Fortbildung. Seiten V1 - V11 (75 Seiten). Landsberg: Ecomed.

Projekte

• ARIDE – Suchtrehabilitation von Opioidsubstituierten in Behandlung mit Depot-Buprenorphin
• IMPELA – Implementierung und Evaluation der S3-Leitlinie zu Screening, Diagnose und Behandlung alkoholbezogener Störungen
• MOMEDA – Monitoring zum Gebrauch von Medikamenten mit Missbrauchs- und Abhängigkeitspotenzial
• PRAGMA – Patient*innenwege von Menschen mit einer Alkoholabhängigkeit in Deutschland